Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα gene
- 15 February 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (4) , 497-502
- https://doi.org/10.1016/0006-2952(91)90620-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivativesJournal of Medicinal Chemistry, 1989
- Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specif ic DNA-binding factorNature, 1989
- Co-localization of rare oligonucleotides and regulatory elements in mammalian upstream gene regionsJournal of Molecular Biology, 1988
- Purification of the c-fos enhancer-binding protein.Molecular and Cellular Biology, 1987
- DNA structure and perturbation by drug bindingBiochemical Journal, 1987
- Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factorsCell, 1986
- Proton NMR studies on the interaction between distamycin A and a symmetrical DNA dodecamerBiochemistry, 1986
- Molecular recognition of B-DNA by Hoechst 33258Nucleic Acids Research, 1985
- DNA structural variations produced by actinomycin and distamycin as revealed by DNAase I footprintingNucleic Acids Research, 1984
- Structure and Synthesis of Distamycin ANature, 1964